Evidence map›Paper›PMID 39424877›Full record

ArticleScientific reports2024

Chromosome 8q24 amplification associated with human hepatocellular carcinoma predicts MYC/ZEB1/MIZ1 transcriptional regulation.

Joeffrey J Chahine, Saniya S Davis, Sumeyye Culfaci, Bhaskar V Kallakury, Pamela L Tuma

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joeffrey J Chahine *Department of Pathology, MedStar Georgetown University Hospital, 20007, Washington, DC, USA.
Saniya S Davis *Department of Biology, The Catholic University of America, 620 Michigan Avenue, NE, 103 McCort-Ward, 20064, Washington, DC, USA.
Sumeyye CulfaciDepartment of Pathology, MedStar Georgetown University Hospital, 20007, Washington, DC, USA.
Bhaskar V KallakuryDepartment of Pathology, MedStar Georgetown University Hospital, 20007, Washington, DC, USA.
Pamela L TumaDepartment of Biology, The Catholic University of America, 620 Michigan Avenue, NE, 103 McCort-Ward, 20064, Washington, DC, USA. tuma@cua.edu.

Funding

Alcohol-induced changes in protein acetylation: mechanisms and consequencesR01AA017626 · NIAAA · CATHOLIC UNIVERSITY OF AMERICA · PI PAMELA L. TUMA · 2010 to 2026
$3.0M
Mechanisms that promote hepatocellular carcinoma due to chronic ethanol exposureR21AA030353 · NIAAA · CATHOLIC UNIVERSITY OF AMERICA · PI TUMA, PAMELA L. · 2023 to 2024
$408k
NIAAA NIH HHS R01 AA017626NIAAA NIH HHS R21 AA030353NIH/NIAAA R01AA017626
6 · The paper itself

Abstract

Genomic instability is associated with late stage carcinomas and the epithelial mesenchymal transition (EMT). Of note is chromosome 8q24 amplification that has been documented in many epithelial-derived carcinomas. On this amplified region is the potent oncogene, c-myc. Not only does MYC overexpression activate targets that promote cell proliferation, it also activates transcription factors that drive EMT, including ZEB1. Further reinforcing EMT, overexpressed MYC also represses tumor suppressors involved in promoting the epithelial phenotype, including MIZ1. We predict that as carcinomas progress, chromosome 8q24 is amplified leading to high MYC levels that leads to ZEB1 expression and MIZ1 repression driving cells through EMT. To interrogate this clinically, limited cohorts of human epithelial-derived carcinomas were examined for MYC/ZEB1/MIZ1 expression patterns across increasing carcinoma grades. Interestingly, the predicted temporal patterns were only observed in hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinomas. Yet MIZ1 proved to be an excellent marker to assess carcinoma progression across types. We expanded the HCC cohort and determined that c-myc amplification was restricted to grade III/IV HCC that also exhibited increased MYC and ZEB1 nuclear expression whereas cytosolic MIZ1 expression was lost and only nuclear expression retained. These same resections were obtained from only individuals who had histories of alcohol consumption that were also diagnosed with cirrhosis, metastasis and had viral hepatitis suggesting etiology-specific mechanisms of cancer progression. Finally, analysis performed in Hep3B cells determined that alterations in MYC expression promoted the predicted changes in ZEB1 and MIZ1 expression and/or distributions and in markers for EMT further suggesting a relationship among these three transcription factors in HCC and their correlation to driving EMT.

Indexed as

Carcinoma, HepatocellularChromosomes, Human, Pair 8Epithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticLiver NeoplasmsProto-Oncogene Proteins c-mycZinc Finger E-box-Binding Homeobox 1Cell Line, TumorFemaleGene AmplificationHumansKruppel-Like Transcription FactorsMaleUbiquitin-Protein LigasesKruppel-Like Transcription FactorsMYC protein, humanProto-Oncogene Proteins c-mycUbiquitin-Protein LigasesZBTB17 protein, humanZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID39424877
PMCPMC11489779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.